logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. HOCH, Kantonsspital St.Gallen, Zentrale Aufnahme

+41714941111
Source: Site record.
https://www.h-och.ch/aufenthalt/anmeldung-auskuenfte

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Zentrale Aufnahme at [Kantonsspital St.Gallen]—the flagship hospital of HOCH Health Ostschweiz in St. Gallen, Switzerland—serves as the primary entry hub for all scheduled inpatient and outpatient medical admissions. Located on the ground floor of Haus 07, this unit manages data registration, patient triage documentation, and initial entry formalities in close coordination with administrative and care teams.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
121Total Trials
Source: Trial-derived.
13Recruiting Trials
Source: Trial-derived.
40Active Trials
Source: Trial-derived.
60Completed Trials
Source: Trial-derived.
147Unique Conditions
Source: Trial-derived.
79Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (4)Source: Trial-derived. Ulcerative Colitis (UC) (4)Source: Trial-derived. Advanced Solid Tumors (3)Source: Trial-derived. Amyotrophic Lateral Sclerosis (3)Source: Trial-derived. Atopic Dermatitis (3)Source: Trial-derived. Bladder Cancer (3)Source: Trial-derived. Prostate Cancer (3)Source: Trial-derived. Atrial Fibrillation (2)

Sponsors

Source: Trial-derived. AbbVie (25)Source: Trial-derived. Swiss Cancer Institute (22)Source: Trial-derived. Merck Sharp & Dohme LLC (10)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Insel Gruppe AG, University Hospital Bern (8)Source: Trial-derived. Bayer (7)Source: Trial-derived. University Hospital, Basel, Switzerland (6)Source: Trial-derived. Daiichi Sankyo (5)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. PET-CT
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Visual acuity assessment